Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis.
Hupe MC, Philippi C, Roth D, Kümpers C, Ribbat-Idel J, Becker F, Joerg V, Duensing S, Lubczyk VH, Kirfel J, Sailer V, Kuefer R, Merseburger AS, Perner S, Offermann A.
Front Oncol. 2018 Dec 20;8:623. doi: 10.3389/fonc.2018.00623. eCollection 2018.
PMID: 30619757
[Implementation of telemedicine in daily care of urological patients].
Struck JP, Wenzel M, Heidenreich A, Merseburger A, Salem J.
Aktuelle Urol. 2018 Dec;49(6):509-514. doi: 10.1055/a-0741-6664. Epub 2018 Dec 6. German.
PMID: 30522161
A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations.
Bex A, Albiges L, Staehler M, Bensalah K, Giles RH, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Fernández-Pello S, Tahbaz R, Abu-Ghanem Y, Volpe A, Ljungberg B, Escudier B, Powles T.
Eur Urol. 2018 Dec;74(6):849-851. doi: 10.1016/j.eururo.2018.08.029. Epub 2018 Sep 7. No abstract available.
PMID: 30201510
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma.
Bex A, Albiges L, Ljungberg B, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Fernández-Pello S, Tahbaz R, Abu-Ghanem Y, Staehler M, Volpe A, Powles T.
Eur Urol. 2018 Dec;74(6):805-809. doi: 10.1016/j.eururo.2018.08.008. Epub 2018 Aug 31.
PMID: 30177291
Retrospective Analysis of Patients With Prostate Cancer Initiating GnRH Agonists/Antagonists Therapy Using a German Claims Database: Epidemiological and Patient Outcomes.
Hupe MC, Hammerer P, Ketz M, Kossack N, Colling C, Merseburger AS.
Front Oncol. 2018 Nov 27;8:543. doi: 10.3389/fonc.2018.00543. eCollection 2018.
PMID: 30538951
Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).
Nicklas AP, Kramer MW, Serth J, Hennenlotter J, Hupe MC, Reimer DU, Stenzl A, Merseburger AS, Kuczyk MA, von Klot CJ.
Adv Ther. 2018 Nov;35(11):2054-2068. doi: 10.1007/s12325-018-0789-7. Epub 2018 Sep 19.
PMID: 30232708
A New Automatically Fixating Stone Basket (2.5 F) Prototype with a Nitinol Spring for Accurate Ureteroscopic Stone Size Measurement.
Cordes J, Nguyen F, Pinkowski W, Merseburger AS, Ozimek T.
Adv Ther. 2018 Sep;35(9):1420-1425. doi: 10.1007/s12325-018-0761-6. Epub 2018 Aug 4.
PMID: 30078174
[Symptomatic renal tumours in metastatic renal cell carcinoma - surgical options].
Gilbert N, Merseburger AS, Kramer M.
Aktuelle Urol. 2018 Sep;49(5):417-421. doi: 10.1055/a-0658-0832. Epub 2018 Sep 5. German.
PMID: 30184600
[Efficacy of metaphylaxis in recurrent urolithiasis].
Hennig MJP, Struck JP.
Urologe A. 2018 Nov;57(11):1373-1374. doi: 10.1007/s00120-018-0792-2. German. No abstract available.
PMID: 30302493
Promise and Implementation of Proteomic Prostate Cancer Biomarkers.
Latosinska A, Frantzi M, Merseburger AS, Mischak H.
Diagnostics (Basel). 2018 Aug 29;8(3). pii: E57. doi: 10.3390/diagnostics8030057. Review.
PMID: 30158500
Extended Techniques of Minimally Invasive Surgery in the Retroperitoneum: Practice Pattern in German Urology Departments.
Hupe MC, Kramer MW, Ozimek T, Merseburger AS, Imkamp F.
Urol Int. 2018;101(3):345-350. doi: 10.1159/000493148. Epub 2018 Sep 18.
PMID: 30227439
[Safety and effectiveness of aquablation for prostatic hyperplasia].
Suarez-Ibarrola R, Salem J, Struck J, Miernik A.
Urologe A. 2018 Nov;57(11):1370-1372. doi: 10.1007/s00120-018-0786-0. German. No abstract available.
PMID: 30302492
[Practice Pattern of Systemic Therapy for Urothelial Cancer in Germany - A Survey of the German Cancer Society].
Hupe MC, Merseburger AS, de Wit M, Rexer H, Gschwend JE, Krege S.
Aktuelle Urol. 2018 Aug;49(4):346-354. doi: 10.1055/a-0645-1076. Epub 2018 Aug 7. German.
PMID: 30086593
Substantial utilization of Facebook, Twitter, YouTube, and Instagram in the prostate cancer community.
Struck JP, Siegel F, Kramer MW, Tsaur I, Heidenreich A, Haferkamp A, Merseburger AS, Salem J, Borgmann H.
World J Urol. 2018 Aug;36(8):1241-1246. doi: 10.1007/s00345-018-2254-2. Epub 2018 Mar 9.
PMID: 29523948
Steep Infundibulopelvic Angle as a New Risk Factor for Flexible Ureteroscope Damage and Complicated Postoperative Course.
Ozimek T, Cordes J, Wiessmeyer JR, Schneider MH, Hupe MC, Gilbert N, Merseburger AS, Kramer MW.
J Endourol. 2018 Jul;32(7):597-602. doi: 10.1089/end.2018.0147. Epub 2018 Jun 7.
PMID: 29737199
[En bloc resection and vaporization techniques for the treatment of bladder cancer].
Struck JP, Karl A, Schwentner C, Herrmann TRW, Kramer MW.
Urologe A. 2018 Jun;57(6):665-672. doi: 10.1007/s00120-018-0625-3. Review. German.
PMID: 29651708
[Intravesical salpingiosis: case report and review of the literature].
Gilbert N, Guo X, Bauer J, Hennig M, Kümpers C, Merseburger AS.
Aktuelle Urol. 2018 Jun;49(3):266-268. doi: 10.1055/s-0043-110039. Epub 2017 Jun 20. German.
PMID: 28633190
Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients.
Hupe MC, Vahlensieck W, Ozimek T, Struck JP, Hennig MJP, Tezval H, von Klot CA, Merseburger AS, Kuczyk MA, Kramer MW.
Urol Oncol. 2018 May;36(5):237.e1-237.e8. doi: 10.1016/j.urolonc.2017.12.014. Epub 2018 Feb 1.
PMID: 29395950
Training, Research, and Working Conditions for Urology Residents in Germany: A Contemporary Survey.
Borgmann H, Arnold HK, Meyer CP, Bründl J, König J, Nestler T, Ruf C, Struck J, Salem J.
Eur Urol Focus. 2018 Apr;4(3):455-460. doi: 10.1016/j.euf.2016.12.001. Epub 2016 Dec 16.
PMID: 28753833
[Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma].
Miller K, Gschwend JE, Merseburger A, Retz M, Stenzl A.
Aktuelle Urol. 2018 Apr;49(2):142-156. doi: 10.1055/s-0043-123067. Epub 2018 Mar 27. German.
PMID: 29587321
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy.
Chen X, Bernemann C, Tolkach Y, Heller M, Nientiedt C, Falkenstein M, Herpel E, Jenzer M, Grüllich C, Jäger D, Sültmann H, Duensing A, Perner S, Cronauer MV, Stephan C, Debus J, Schrader AJ, Kristiansen G, Hohenfellner M, Duensing S.
Urol Oncol. 2018 Apr;36(4):161.e19-161.e30. doi: 10.1016/j.urolonc.2017.11.001. Epub 2017 Dec 1.
PMID: 29198908
[Utility Analysis of Oncological Centre Building in the Field of Colorectal Cancer].
Weinhold I, Keck T, Merseburger A, Rody A, Wollenberg B, Wende D, Häckl D, Elsner C.
Zentralbl Chir. 2018 Apr;143(2):181-192. doi: 10.1055/s-0042-122854. Epub 2017 May 4. German.
PMID: 28472845
Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD, Talukder A, Yates TJ, Hennig MJP, Garcia-Roig M, Lahorewala SS, Mullani NN, Klaassen Z, Kava BR, Manoharan M, Soloway MS, Lokeshwar VB.
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):464-472. doi: 10.1158/1055-9965.EPI-17-0700. Epub 2018 Feb 12.
PMID: 29440068
Urinary CE-MS peptide marker pattern for detection of solid tumors.
Belczacka I, Latosinska A, Siwy J, Metzger J, Merseburger AS, Mischak H, Vlahou A, Frantzi M, Jankowski V.
Sci Rep. 2018 Mar 27;8(1):5227. doi: 10.1038/s41598-018-23585-y.
PMID: 29588543
A Real-World Data Study to Evaluate Treatment Patterns, Clinical Characteristics and Survival Outcomes for First- and Second-Line Treatment in Locally Advanced and Metastatic Urothelial Cancer Patients in Germany.
Niegisch G, Gerullis H, Lin SW, Pavlova J, Gondos A, Rudolph A, Haas G, Hennies N, Kramer MW.
J Cancer. 2018 Mar 29;9(8):1337-1348. doi: 10.7150/jca.23162. eCollection 2018.
PMID: 29721042
Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice.
Dogan S, Hennig M, Frank T, Struck JP, Cebulla A, Salem J, Borgmann H, Klatte T, Merseburger AS, Kramer M, Hofbauer SL.
Urol Int. 2018;101(1):25-30. doi: 10.1159/000487405. Epub 2018 Mar 6.
PMID: 29510388
Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H.
Proteomics Clin Appl. 2018 Mar;12(2). doi: 10.1002/prca.201700074. Epub 2017 Oct 25. Review.
PMID: 28980455
[Inhibitors of the androgen receptor N‑terminal domain : Therapies targeting the Achilles' heel of various androgen receptor molecules in advanced prostate cancer].
Hupe MC, Offermann A, Perabo F, Chandhasin C, Perner S, Merseburger AS, Cronauer MV.
Urologe A. 2018 Feb;57(2):148-154. doi: 10.1007/s00120-017-0541-y. Review. German.
PMID: 29147733
[The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer].
Thelen P, Taubert H, Duensing S, Kristiansen G, Merseburger AS, Cronauer MV.
Aktuelle Urol. 2018 Jan 25. doi: 10.1055/s-0043-115426. [Epub ahead of print] German.
PMID: 29370587
Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition.
Tahbaz R, Schmid M, Merseburger AS.
Curr Opin Urol. 2018 Jan;28(1):62-79. doi: 10.1097/MOU.0000000000000454. Review.
PMID: 29059103